Jiating Huang

Jiating Huang

Auto-generated profile, based on publicly available information

Jiating Huang

Department of Endocrinology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Children and Adolescents’ Health and Diseases, Hangzhou, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Pharmacological Research
Verified
Journal Article
Closed access
JHJia-Ting Huang
Jia-Ting Huang
YMYu-Qin Mao
Yu-Qin Mao
BHBing Han
Bing Han
ZZZhengyan Zhang
Zhengyan Zhang
Huiling ChenHuiling Chen
Huiling Chen
Li-Shun WangLi-Shun Wang
Li-Shun Wang

8 August 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
CXCuifang Xu
Cuifang Xu
JHJiating Huang
Jiating Huang
YGYongqiang Gao
Yongqiang Gao
WZWeixing Zhao
Weixing Zhao
YSYiqi Shen
Yiqi Shen
YNYan Ni
Yan Ni
Gut dysbiosis is closely associated with obesity and related metabolic diseases including type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD). The gut microbial features and biomarkers have been increasingly investigated in recent studies, which require further validation due to the limited sample size and various confounding factors that may affect microbial compositions. So far, it lacks a comprehensive bioinformatics pipeline providing automated statistical analysis and integrating independent studies for cross validation simultaneously. OBMeta aims to streamline the standard metagenomics data analysis from diversity analysis, comparative analysis, functional analysis, to co-abundance network analysis. In addition, a curated database has been established with a total of 88 public research projects, covering three different phenotypes (Obesity, T2D, and NAFLD) and more than five different intervention strategies (exercise, diet, probiotics, medication, and surgery). With OBMeta, users can not only analyze their own research projects, but also search and match public datasets of interest for cross-project validation. Moreover, OBMeta provides cross-phenotype and cross-intervention-based advanced validation that maximally supports preliminary findings from an individual study. To summarize, OBMeta is a comprehensive web server to analyze and validate gut microbial features and biomarkers for obesity-associated metabolic diseases. OBMeta is freely available at: http://obmeta.met-bioinformatics.cn/ . Abstract Figure:

11 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JHJiating Huang
Jiating Huang
XZXuelian Zhou
Xuelian Zhou
HWHuiying Wang
Huiying Wang
ALAna Liu
Ana Liu
JFJunfen Fu
Junfen Fu
YNYan Ni
Yan Ni
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent pediatric disorder with limited treatment options, primarily due to an incomplete understanding of its molecular drivers. Recent research underscores the role of microbial guilds in metabolic health, but the mechanisms by which dysbiosis driven by core species and co-abundant symbionts disrupt metabolic homeostasis in pediatric MASLD remain unclear. Results: Here, we conducted integrated metagenomic and metabolomic analyses on 285 pediatric subjects including MASLD patients, obese and healthy controls. The gut dysbiosis in MASLD was characterized by a depletion of Phocaeicola vulgatus , Bacteroides uniformis , Parabacteroides distasonis , and Bacteroides thetaiotaomicron . Co-abundance network analysis, integrating our cohort with four public datasets, identified these species as core guild members associated with MASLD. Microbial enrichment analysis showed significant disruptions in carbohydrate metabolism, particularly the downregulation of the tricarboxylic acid (TCA) cycle, fructose and sucrose metabolism, and pentose and glucuronate interconversions. P. vulgatus and B. uniformis were identified as dominant species linked to the downregulation of KEGG orthologs (KOs) in these disrupted pathways that were inversely correlated with hepatic injury biomarkers. CAZyme database analysis further emphasized P. vulgatus as the primary contributor to glycoside hydrolases involved in monosaccharide utilization. Finally, both untargeted and targeted metabolomics analysis validated a disrupted metabolic network centered on the TCA cycle and monosaccharide metabolism in pediatric MASLD. Conclusion: Our findings suggest the core guild species P. vulgatus and B. uniformis may serve as critical regulators of carbohydrate metabolism in pediatric MASLD, offering potential mechanistic targets for gut microbiome-based interventions.